School of Medicine


Showing 1-10 of 47 Results

  • Ana E. Pacheco-Navarro

    Ana E. Pacheco-Navarro

    Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
    Postdoctoral Scholar, Pulmonary and Critical Care Medicine

    BioDr. Pacheco-Navarro is a pulmonary and critical care physician with a research interest in long term outcomes after critical illness and the intersection of critical illness and autoimmunity.

  • Natalie Pageler

    Natalie Pageler

    Clinical Professor, Peds/Clinical Informatics
    Clinical Professor, Medicine - Biomedical Informatics Research

    Current Research and Scholarly InterestsIn my administrative role, I oversee the development and maintenance of clinical decision support tools within the electronic medical record. These clinical decision support tools are designed to enhance patient safety, efficiency, and quality of care. My research focuses on rigorously evaluating--1) how these tools affect clinician knowledge, attitudes, and behaviors; and 2) how these tools affect clinical outcomes and efficiency of health care delivery.

  • Neda Pakdaman

    Neda Pakdaman

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Pakdaman practices Internal Medicine in Silicon Valley. She received her medical education at Yale University School of Medicine where she earned the Janet M. Glasgow Memorial Achievement Award for Women in Medicine. She completed her residency in Internal Medicine at Stanford University Hospital and was nominated for the Alwin Rambar-James Mark Award for Excellence in Patient Care.

    Dr. Pakdaman has been involved in developing innovative models for patient centered practice delivery. She has extensive background in Concierge Medicine as well as Executive Medicine. In addition, prior to coming to Stanford, she helped initiate and served as medical director for the Palliative Care inpatient consult service at El Camino Hospital. During that time, she served as chair of the El Camino Hospital Ethics Committee and as an advisory member for the Genomics Medicine Institute at El Camino Hospital. Drawing from her experiences working in both executive health programs and retainer based practices, she joined Stanford in 2012 to help launch Stanford Concierge Medicine. She subsequently served as the Medical Director of Stanford Concierge Medicine and Stanford Executive Health for five years where she helped pilot aspects of Stanford Precision Health platform.

    Dr. Pakdaman's clinical focus is adult primary care with health promotion and disease prevention/management.

    Board Certified Internal Medicine 2003, 2013
    Board Certified Hospice and Palliative Medicine 2008, 2018

  • Latha Palaniappan, MD, MS

    Latha Palaniappan, MD, MS

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.

  • Jonathan P. Palma

    Jonathan P. Palma

    Clinical Professor, Medicine - Biomedical Informatics Research

    Current Research and Scholarly InterestsInterventional informatics to achieve examples of a learning healthcare system; optimization of commercial EMRs to support complex clinical workflows in newborn intensive care; clinical decision support; real-time clinical dashboards; electronic sign-out tools; IT-supported patient/family communication.

  • Minggui Pan, MD, PhD

    Minggui Pan, MD, PhD

    Clinical Professor, Medicine - Oncology

    BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.

    He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.

    Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.

    He has published more than fifty papers and many abstracts and presented in many cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, JCO Oncology Practice, Journal of Hematology and Oncology, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology, Chinese Society Of Clinical Oncology, Connective Tissue Oncology Society and others.

    Dr. Pan is a member of American Society of Clinical Oncology, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research.

  • Hemali Vijay Panchal

    Hemali Vijay Panchal

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly InterestsQuality Improvement, Patient Safety, Medical Education

  • Alan C. Pao

    Alan C. Pao

    Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
    On Leave from 07/01/2023 To 12/31/2023

    Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.